Therefore, it is important to elucidate signaling pathways involved in sulbactam-induced GLT-1 up-regulation and anti-ischemic effect for promoting the clinical application of sulbactam as an anti-cerebral ischemia medication. This evidence concerns the gene SLC1A2 and brain ischemia.